Tennessee Retina, P.C.

Nashville, Tennessee 37203

Use our guide to learn which trials are right for you!

We've found
9 trials
at this facility
Neovascular Age-Related Macular Degeneration Clinical Trial
Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Wet Macular Degeneration Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Extension Study for the Port Delivery System With Ranibizumab (Portal)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Diabetic Macular Edema Clinical Trial
A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Age-Related Macular Degeneration Clinical Trial
A Phase 1b Dose Escalation Evaluation of Safety and Tolerability and a Phase 2 Proof of Concept Investigation of Efficacy and Safety of ASP7317 for Atrophy Secondary to Age-related Macular Degeneration
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Geographic Atrophy Clinical Trial
Study to Compare the Efficacy and Safety of Intravitreal APL-2 Therapy With Sham Injections in Patients With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
A Phase III Study to Evaluate the Port Delivery System Implant With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration (Archway)
Status: Enrolling, Phase III
Updated: 12/31/1969
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials
Neovascular Age-Related Macular Degeneration Clinical Trial
Two-week Retreatment Interval Study for Treated Age-related Macular Degeneration Refractory to Monthly Aflibercept
Status: Upcoming, Phase IV
Updated: 4/18/2018
Tennessee Retina, P.C.
mi
from
Nashville, TN
Click here to add this to my saved trials